BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8969737)

  • 21. Comparative evaluation of NBUVB phototherapy and PUVA photochemotherapy in chronic plaque psoriasis.
    Dayal S; ; Jain VK
    Indian J Dermatol Venereol Leprol; 2010; 76(5):533-7. PubMed ID: 20826993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
    Harnes DK; Thune P
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
    Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
    J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment.
    Stern RS; Lange R
    J Invest Dermatol; 1988 Aug; 91(2):120-4. PubMed ID: 3397587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Photocarcinogenesis].
    Amblard P; Béani JC; Reymond JL; Didier-Roberto B
    Ann Dermatol Venereol; 1987; 114(3):381-94. PubMed ID: 3300507
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous malignancies in patients treated with psoralen photochemotherapy (PUVA) for vitiligo.
    Halder RM; Battle EF; Smith EM
    Arch Dermatol; 1995 Jun; 131(6):734-5. PubMed ID: 7778934
    [No Abstract]   [Full Text] [Related]  

  • 32. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient.
    Woo TY; Wong RC; Wong JM; Anderson TF; Lerman S
    Arch Dermatol; 1985 Oct; 121(10):1307-8. PubMed ID: 4037825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks and benefits of the treatment of psoriasis.
    Epstein JH
    N Engl J Med; 1979 Apr; 300(15):852-3. PubMed ID: 423922
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant melanoma in a patient with severe psoriasis treated by oral methoxsalen photochemotherapy.
    Frenk E
    Dermatologica; 1983; 167(3):152-4. PubMed ID: 6414855
    [No Abstract]   [Full Text] [Related]  

  • 36. British Photodermatology Group guidelines for PUVA.
    Br J Dermatol; 1994 Feb; 130(2):246-55. PubMed ID: 8123580
    [No Abstract]   [Full Text] [Related]  

  • 37. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
    Stern RS; Lange R
    Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutagenicity and carcinogenicity of methoxsalen plus UV-A.
    Roelandts R
    Arch Dermatol; 1984 May; 120(5):662-9. PubMed ID: 6372701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of skin cancer to PUVA therapy in Australia.
    Lobel E; Paver K; King R; Le Guay J; Poyzer K; Wargon O
    Australas J Dermatol; 1981 Dec; 22(3):100-3. PubMed ID: 7344686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.